MBX Biosciences Common Stock (MBX) Depreciation And Amortization

Annual D&A

$157.00 K
+$101.00 K+180.36%

01 December 2023

All-time High

$157.00 K
MBX annual depreciation & amortization is currently at an all-time high
Annual Total Expenses$35.31 M
MBX annual total expenses is $35.31 million
Annual Operating Expenses$35.31 M
MBX annual total operating expenses is $35.31 million
Annual Net Income-$32.56 M
MBX annual net profit is -$32.56 million

MBX Depreciation And Amortization Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly D&A

$75.00 K
0.00%

30 September 2024

All-time High

$75.00 K
MBX quarterly depreciation & amortization is currently at an all-time high
Quarterly Total Expenses$19.61 M
MBX quarterly total expenses is $19.61 million
Quarterly Operating Expenses$19.61 M
MBX quarterly total operating expenses is $19.61 million
Quarterly Revenue$0.00
MBX quarterly revenue is $0.00
Quarterly Net Income-$18.14 M
MBX quarterly net profit is -$18.14 million

MBX Quarterly D&A Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM D&A

$75.00 K
0.00%

30 September 2024

All-time High

$75.00 K
MBX TTM depreciation & amortization is currently at an all-time high
Annual Total Expenses$35.31 M
MBX annual total expenses is $35.31 million
Annual Operating Expenses$35.31 M
MBX annual total operating expenses is $35.31 million
TTM Revenue$0.00
MBX TTM revenue is $0.00
TTM Net Income-$18.14 M
MBX TTM net profit is -$18.14 million

MBX TTM D&A Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

MBX Depreciation And Amortization Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year---
3 y3 years---
5 y5 years---

MBX Depreciation And Amortization High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 years
5 y5 years
alltimeall timeat highat highat high

MBX Biosciences Common Stock Depreciation And Amortization History

DateAnnualQuarterlyTTM
Sept 2024
-
$75.00 K(+87.5%)
$75.00 K(+87.5%)
Dec 2023
$157.00 K
-
-
DateAnnualQuarterlyTTM
Sept 2023
-
$40.00 K
$40.00 K
Dec 2022
$56.00 K
-
-

FAQ

  • What is MBX Biosciences Common Stock annual depreciation & amortization?
  • What is the all time high annual D&A for MBX Biosciences Common Stock?
  • What is MBX Biosciences Common Stock quarterly depreciation & amortization?
  • What is the all time high quarterly D&A for MBX Biosciences Common Stock?
  • What is MBX Biosciences Common Stock TTM depreciation & amortization?
  • What is the all time high TTM D&A for MBX Biosciences Common Stock?

What is MBX Biosciences Common Stock annual depreciation & amortization?

The current annual D&A of MBX is $157.00 K

What is the all time high annual D&A for MBX Biosciences Common Stock?

MBX Biosciences Common Stock all-time high annual depreciation & amortization is $157.00 K

What is MBX Biosciences Common Stock quarterly depreciation & amortization?

The current quarterly D&A of MBX is $75.00 K

What is the all time high quarterly D&A for MBX Biosciences Common Stock?

MBX Biosciences Common Stock all-time high quarterly depreciation & amortization is $75.00 K

What is MBX Biosciences Common Stock TTM depreciation & amortization?

The current TTM D&A of MBX is $75.00 K

What is the all time high TTM D&A for MBX Biosciences Common Stock?

MBX Biosciences Common Stock all-time high TTM depreciation & amortization is $75.00 K